ResMed Profit Margin 2012-2025 | RMD

Current and historical gross margin, operating margin and net profit margin for ResMed (RMD) over the last 10 years. Profit margin can be defined as the percentage of revenue that a company retains as income after the deduction of expenses. ResMed net profit margin as of September 30, 2025 is 27.35%.
Sector Industry Market Cap Revenue
Medical Medical Products Manufacturing $37.629B $5.146B
ResMed, Inc. holds a major position as designer, manufacturer, as well as a distributor in the worldwide market for generators, masks, and related accessories for the treatment of sleep-disordered breathing (SDB) and other respiratory disorders. SDB includes obstructive sleep apnea (OSA) and other respiratory disorders that occur during sleep. The company currently has two operating segments, which are the Sleep and Respiratory Care segment and the Software-as-a-Service segment.
Stock Name Country Market Cap PE Ratio
Abbott Laboratories (ABT) United States $216.733B 24.98
EssilorLuxottica (ESLOY) France $149.439B 0.00
Boston Scientific (BSX) United States $141.899B 32.45
Stryker (SYK) United States $138.196B 27.44
Medtronic (MDT) Ireland $124.291B 17.22
Medline (MDLN) United States $56.122B 0.00
Lonza Group Ag (LZAGY) Switzerland $49.743B 0.00
Agilent Technologies (A) United States $41.955B 26.52
GE HealthCare Technologies (GEHC) United States $39.585B 18.93
Koninklijke Philips (PHG) Netherlands $28.695B 18.74
Terumo (TRUMY) Japan $21.868B 24.62
Insulet (PODD) United States $19.595B 60.82
Zimmer Biomet Holdings (ZBH) United States $18.124B 11.30
Smith & Nephew SNATS (SNN) United Kingdom $14.309B 0.00
Baxter (BAX) United States $10.358B 8.36
Sunny Optical Technology (SNPTF) China $9.589B 0.00
Bio-Rad Laboratories (BIO) United States $8.713B 31.33
Demant (WILYY) Denmark $7.372B 0.00
BillionToOne (BLLN) United States $4.538B 0.00
Lantheus Holdings (LNTH) United States $4.475B 13.63
Haemonetics (HAE) United States $3.881B 17.27
Envista Holdings (NVST) United States $3.844B 22.06
ICU Medical (ICUI) United States $3.732B 23.70
Prestige Consumer Healthcare (PBH) United States $3.140B 14.32
Shandong Weigao Medical Polymer (SHWGF) China $3.099B 0.00
QuidelOrtho (QDEL) United States $2.266B 14.57
Perrigo (PRGO) Ireland $2.056B 5.15
Neogen (NEOG) United States $2.038B 44.62
LeMaitre Vascular (LMAT) United States $1.902B 38.28
AtriCure (ATRC) United States $1.871B 0.00
Curaleaf Holdings (CURLF) Canada $1.845B 0.00
Green Thumb Industries (GTBIF) United States $1.819B 79.73
Phibro Animal Health (PAHC) United States $1.614B 16.13
Lumexa Imaging Holdings (LMRI) United States $1.496B 0.00
AdaptHealth (AHCO) United States $1.436B 20.78
Kestra Medical Technologies (KMTS) United States $1.366B 0.00
BioLife Solutions (BLFS) United States $1.157B 343.43
Capricor Therapeutics (CAPR) United States $1.121B 0.00
Tilray Brands (TLRY) Canada $1.044B 0.00
Maravai LifeSciences Holdings (MRVI) United States $1.007B 0.00
InMode (INMD) Israel $0.916B 10.35
Omeros (OMER) United States $0.909B 0.00
CeriBell (CBLL) United States $0.869B 0.00
Valneva SE (VALN) France $0.840B 0.00
VAREX IMAGING (VREX) United States $0.558B 15.12
Cresco Labs (CRLBF) United States $0.497B 0.00
Verano Holdings (VRNO) United States $0.489B 0.00
Brainsway (BWAY) Israel $0.474B 80.63
Canopy Growth (CGC) Canada $0.453B 0.00
SNDL (SNDL) Canada $0.436B 0.00
Cerus (CERS) United States $0.436B 0.00
Evolus (EOLS) United States $0.374B 0.00
Quanterix (QTRX) United States $0.344B 0.00
SEMPERIT AG HLD (SEIGY) Austria $0.317B 0.00
TriSalus Life Sciences (TLSI) United States $0.293B 0.00
Viemed Healthcare (VMD) United States $0.278B 22.12
TerrAscend (TSNDF) Canada $0.259B 0.00
Sanuwave Health (SNWV) United States $0.252B 0.00
Aurora Cannabis (ACB) Canada $0.241B 142.00
High Tide (HITI) Canada $0.238B 0.00
Organigram Global (OGI) Canada $0.232B 0.00
Owens & Minor (OMI) United States $0.217B 2.17
Sanara MedTech (SMTI) United States $0.213B 0.00
Accendra Health (ACH) United States $0.207B 2.08
Vireo Growth (VREOF) United States $0.204B 0.00
OraSure Technologies (OSUR) United States $0.193B 0.00
Utah Medical Products (UTMD) United States $0.192B 16.92
Quipt Home Medical (QIPT) United States $0.154B 0.00
Apyx Medical (APYX) United States $0.153B 0.00
FitLife Brands (FTLF) United States $0.146B 0.00
Oramed Pharmaceuticals (ORMP) United States $0.137B 0.00
Exagen (XGN) United States $0.135B 0.00
Jushi Holdings (JUSHF) United States $0.120B 0.00
Fonar (FONR) United States $0.115B 16.75
Biote (BTMD) United States $0.115B 5.02
MacroGenics (MGNX) United States $0.113B 0.00
ImmuCell (ICCC) United States $0.060B 25.65
Sharps Technology (STSS) United States $0.059B 0.00
Nephros (NEPH) United States $0.048B 34.92
Cytosorbents (CTSO) United States $0.044B 0.00
Rockwell Medical (RMTI) United States $0.039B 0.00
Jin Medical (ZJYL) China $0.039B 0.00
Modular Medical (MODD) United States $0.037B 0.00
Veru (VERU) United States $0.036B 0.00
United-Guardian (UG) United States $0.029B 14.47
Allurion Technologies (ALUR) United States $0.017B 0.00
Cellectar Biosciences (CLRB) United States $0.016B 0.00
Bonk (BNKK) United States $0.015B 0.00
INLIF (INLF) China $0.009B 0.00
Innovative Eyewear (LUCY) United States $0.009B 0.00
Flora Growth (FLGC) United States $0.007B 0.00
IM Cannabis (IMCC) Canada $0.007B 0.00
Zynex (ZYXI) United States $0.004B 0.00
Agape ATP (ATPC) $0.004B 0.00
GlucoTrack (GCTK) United States $0.003B 0.00
Functional Brands (MEHA) United States $0.003B 0.00
Meihua Medical Technologies (MHUA) China $0.002B 0.00
Akanda (AKAN) Canada $0.000B 0.00
InterCure (INCR) Israel $0.000B 0.00
InVivo Therapeutics Holdings (NVIVQ) United States $0.000B 0.00
Trinity Biotech (TRIB) Ireland $0.000B 0.00